Cardioprotection with resveratrol pretreatment: Improved beneficial effects over standard treatment in rat hearts after global ischemia

Scandinavian Cardiovascular Journal

Volumn 38, Issue 4, 2004, Pages 245-254

  Dernek, S ^a   Ikizler, Murat ^a,d   Erkasap, N ^a   Ergun, B ^b   Koken, T ^c   Yilmaz, K ^c   Sevin, B ^a   Kaygisiz, Z ^a   Kural, T ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b ANADOLU UNIVERSITY   (Turkey)

^c AFYON KOCATEPE UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Antioxidant; Ischemia; Pretreatment; Reperfusion; Resveratrol

Indexed keywords

CARBONYL DERIVATIVE; CREATINE KINASE MB; GLUTATHIONE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MYOGLOBIN; RESVERATROL; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOSE RESPONSE; DRUG INFUSION; DRUG POTENCY; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; ISOLATED HEART; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; TISSUE HOMOGENATE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; STILBENES; SURVIVAL RATE;

EID: 4444219725     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430410035476     Document Type: Article

References (41)

1. Hearse DJ. Myocardial ischemia: Can we agree on a definition for the 21st century? Cardiovasc Res 1994, 28(12): 1737-1744.
2. Zimmerman AN, Hulsmann WC. Paradoxical influence of calcium ions on the permeability of the cell membranes in the isolated rat heart. Nature 1966; 211: 646-647.
3. Hearse DJ, Humphrey SM, Bullock GR. The oxygen paradox and the calcium paradox: Two facets of the same problem? J Mol Cell Cardiol 1978; 10(7): 641-668.
4. Hearse DJ, Humphrey SM, Nayler WG, Slade A, Border D. Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol 1975; 7: 315-324.
5. Renaud SC, Gueguen R, Schenker J, d'Houtaud A. Alcohol and mortality in middle-aged men from eastern France. Epidemiology 1998; 9: 184-188.
6. Law M, Wald N. Why heart disease mortality is low in France: The time lag explanation. Br Med J 1999 May 29; 318(7196): 1471-1476.
7. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the "French Paradox" . Eur J Endocrinol 1998; 138: 619-620.
8. Bertelli AA, Giovannini L, Giannessi D, et al. Antiplatelet activity of synthetic and natural resveratrol in red wine. Int J Tissue React 1995; 17: 1-3.
9. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-1104.
10. Sun AY, Chen YM, James-Kracke M, Wixom P, Cheng Y. Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochem Res 1997; 22: 1187-1192.
11. Maulik N, Engelman DT, Watanabe M, et al. Nitric oxide signaling in ischemic heart. Cardiovasc Res 1995; 30: 593-601.
12. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 1999; 27: 160-169.
13. Floreani M, Napoli E, Quintieri L, Palatini P. Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci 2003; 72: 2741-2750.
14. Asha S, Radha E. Effect of age and myocardial infarction on serum and heart lactic dehydrogenase. Exp Gerontol 1985, 20(1): 67-70.
15. Gerhardt W, Ljungdahl L, Herbert AK. Troponin T and CK-MB (mass) in early diagnosis of ischemic myocardial injury. Clin Biochem 1993; 26(4): 231-240.
16. Bertinchant JP, Larue C, Pernel I, et al. Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem 1996; 29(6): 587-594.
17. Bhayana V, Henderson AR. Biochemical markers of myocardial damage. Clin Biochem 1995; 28: 1-29.
18. Beutler E. The glutathione instability of drug sensitive red cells; A new method for the in vitro detection of drug sensitivity. J Lab Clin Med 1957; 49: 84-95.
19. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
20. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478.
21. Kaul N, Siveski-Iliskovic N, Hill M, Slezak J, Singal PK. Free radicals and the heart. J Pharmacol Toxicol Methods 1993; 30: 55-67.
22. Zweier JL. Measurement of superoxide-derived free radicals in the reperfused heart: Evidence for a free radical mechanism of reperfusion injury. J Biol Chem 1988; 263: 1353-1357.
23. Das DK, Engelmann RM, Rousou JA, Breyer RH, Otani H, Lemeshow S. Pathophysiology of superoxide radicals as potential mediator of reperfusion injury in pig heart. Basic Res Cardiol 1986; 81: 155-166.
24. Robicsek F, Schaper J. Reperfusion injury: Fact or myth? J Cardiac Surg 1997; 12: 133-137.
25. Das DK, Maulik N. Antioxidant effectiveness in ischemia-reperfusion tissue injury. Methods Enzymol 1994; 233: 601-610.
26. Singal PK, Khaper N, Palace V, Kumar D. The role of oxidative stress in the genesis of heart disease. Cardiovasc Res 1998; 40: 426-432.
27. Axford-Gatley RA, Wilson GJ. Reduction of experimental myocardial infarct size by oral administration of alpha tocopherol. Cardivasc Res 1991; 25: 89-92.
28. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449.
29. Hain R, Bieseler B, Kindl H, Schroder G, Stocker R. Expression of a stilbene synthase gene in Nicotiana tabacum results in synthesis of the phytolaxin resveratrol. Plant Mol Biol 1990; 2: 325-335.
30. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grape. Cardiovasc Res 2000; 47(3): 549-555.
31. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002; 71(6): 655-665.
32. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK. Pharmacological preconditioning with resveratrol: An insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 2002 Jun; 282(6): 1996-2003.
33. Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A. Kinetics of trans- and cis-resveratrol after red wine oral administration in rats. Int J Clin Pharmacol Res 1996; 16: 77-81.
34. Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drug Exp Clin Res 1998; 24: 133-138.
35. Bradamante S, Piccinini F, Barenghi L, et al. Does resveratrol induce pharmacological preconditioning? Int J Tissue React 2000: 22(1): 1-4.
36. Blardi P, De Lalla A, Volpi L, Di Perri T. Stimulation of endogenous adenosine release by oral administration of quercetin and resveratrol in man. Drugs Exp Clin Res 1999; 25: 105-110.
37. Qiu Y, Rizvi A, Tand XL, et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol 1997; 273: 2931-2936.
38. Fitzpatrick DF, Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 1993; 265: 774-778.
39. Weiss HR, Rodriguez E, Tse J, Scholz PM. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin Exp Pharmacol Physiol 1994; 21: 607-614.
40. Chen CK, Pace-Asciak CR. Vasorelaxing activity of resveratrol and quercetin in isolate rat aorta. Gen Pharmacol 1996; 27: 363-366.
41. Hung LM, Su MJ, Chu WK, Chiao CW, Chan WF, Chen JK. The protective effect of resveratrol on ischemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 2002 Apr: 135(7): 1627-1633.